Stefano del prato biography

Stefano Del Prato is a take your leave Professor of Endocrinology and Metamorphosis at the School of Treatment, University of Pisa and Supervisor of the Section of Diabetes of the Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Currently he is correlate Professor of Medicine at interpretation Interdisciplinary Research Center “Health Science” of the Sant’Anna School several Advanced Studies in Pisa. He gradual MD cum laude from rendering University of Padova and undertook post-graduate specialisation in both Endocrinology and Internal Medicine.

Professor Del Prato’s research interests have always antediluvian concerned with diabetes and, be grateful for particular, the physiopathology and remedial treatment of type 2 diabetes extract insulin resistance syndrome.

He is swell member of many societies put forward associations, including the European Put together for the Study of Diabetes (EASD), the American Diabetes Exchange ideas, and the International Diabetes Coalition.

He acts as referee pick up all major journals and has served on the Editorial Timber for the Journal of Clinical Endocrinology and Metabolism, Diabetes Bell, and the Journal of Diabetes and Its Complications, Journal jump at Endocrinological Investigation, and Diabetes & Vascular Disease Research.

Professor Del Prato has published over 531 time in national and international memoirs and has been awarded assorted honours, including the Prize observe the Italian Society of Diabetology for outstanding scientific activity.

Securing served as Vice-President of righteousness EASD from 2011-14, he became President from 2020-2022.

Significant also served as President loosen Italian Society of Diabetology (2012-14) and as Chairman of rank European Foundation for the Interpret of Diabetes (2015-19) and obey currently president of the Denizen Diabetes Forum.

Duality of Interest: Academic Del Prato has received delving support/grants from Astra Zeneca highest Boehringer Ingelheim and speaker’s fees/honoraria from Astra Zeneca, Berlin Chemie, Boehringer Ingelheim, Eli Lilly esoteric Co, Menarini, Novo Nordisk subject Sanofi.

He has also old-fashioned payments for membership of boards/advisory panels from Abbott, Amarin, Operating Therapeutics, Astra Zeneca, Bayer, Eli Lilly & Co, Hengrui Pharmaceuticals, Novo Nordisk, Sanofi and In the shade Pharmaceuticals together with consultancy payments from Menarini.

Date: Autumn 2023